Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zomedica Pharmaceuticals Corp
(NY:
ZOM
)
0.1361
-0.0228 (-14.35%)
Official Closing Price
Updated: 8:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Zomedica Pharmaceuticals Corp
< Previous
1
2
3
4
5
6
Next >
Here's What's Going On With Zomedica Shares
August 16, 2022
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results. What Happened?
Via
Benzinga
Coinbase, Moderna And 56 Biggest Movers From Yesterday
July 07, 2022
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...
Via
Benzinga
Why Is SCWorx (WORX) Stock Up 37% Today?
July 06, 2022
SCWorx (WORX) stock is rocketing higher on Wednesday after boosting investor confidence with a stock purchase agreement!
Via
InvestorPlace
ZOM Stock Pops 5% as Zomedica Acquires Revo Squared
July 06, 2022
ZOM stock is on the rise as Zomedica acquires crucial technology that will provide veterinarians with enhanced diagnostic imaging quality.
Via
InvestorPlace
Dogs Win, Investors Lose With Zomedica
March 24, 2022
Zomedica still has cash from pushing its Truforma device last year, but the future of ZOM stock is based on PulseNet, bought in October.
Via
InvestorPlace
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
March 09, 2022
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales.
Via
InvestorPlace
Why Zomedica Shares Are Falling Today
May 11, 2022
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 28, 2022
During Thursday, 849 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 27, 2022
Wednesday's session saw 784 companies set new 52-week lows.
Via
Benzinga
Continue to Steer Clear of MULN Stock
April 27, 2022
Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment.
Via
InvestorPlace
Zomedica’s Shareholders Should Be Worried About the Outlook of ZOM Stock
February 16, 2022
ZOM stock has been a toxic asset for nearly a year, and Zomedica isn't giving investors much to get enthused about.
Via
InvestorPlace
Earnings Scheduled For May 10, 2022
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Via
Benzinga
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
March 03, 2022
ΖΟM stock is a penny stock that is trying to make a turnaround. A positive catalyst is present in the form of sales growth.
Via
InvestorPlace
Earnings Scheduled For February 25, 2022
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
My Top Things To Expect This Week
February 22, 2022
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for.
Via
InvestorPlace
26 Stocks Moving in Friday's Pre-Market Session
February 18, 2022
Gainers Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started...
Via
Benzinga
Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware
January 21, 2022
So when an intriguing acquisition has failed to boost ZOM stock, investors should ask why that’s the case.
Via
InvestorPlace
3 Most-Shorted Stocks at 52-Week Lows to Buy
January 07, 2022
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors.
Via
InvestorPlace
56 Biggest Movers From Yesterday
February 17, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...
Via
Benzinga
There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker
January 07, 2022
ZOM stock is far from a market darling, but an underreported acquisition could breathe new life into Zomedia's struggling business.
Via
InvestorPlace
Zomedica Remains a Speculative Play in the Veterinary Field
January 04, 2022
The dismal run of ZOM Stock likely to continue for the foreseeable future, until it meaningfully improves its top and bottom-line numbers.
Via
InvestorPlace
Analysis: Robinhood's 2 Top Losers From Its 'Most Popular' Watchlist
December 31, 2021
Centro Electric Group Ltd. (NASDAQ:NAKD) and Zomed...
Via
Benzinga
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
December 16, 2021
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022.
Via
InvestorPlace
7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out
December 09, 2021
Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today?
December 08, 2021
Penny stocks are still a hot topic among retail traders and we're covering some of the top ones to watch Wednesday that are on the move.
Via
InvestorPlace
22 Stocks Moving in Wednesday's Pre-Market Session
December 08, 2021
Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment...
Via
Benzinga
Exposures
Product Safety
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.
Via
InvestorPlace
Zomedica Stock Looks Tempting Here, But There’s Likely More Downside
December 03, 2021
Early in 2021, ZOM stock was part of the meme stock trade, but recent catalysts suggest it may be moving toward investment territory.
Via
InvestorPlace
Zomedica Is Languishing Today, but Keep an Eye on This Risky Play
November 17, 2021
It's a risky play no doubt, but ZOM stock stands to get out of its current rut as a key temporary issue subsides.
Via
InvestorPlace
7 Penny Stocks That Could Have an Explosive Year-End
November 05, 2021
While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.
Via
InvestorPlace
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.